Brain metastases in her2-positive breast cancer: new opportunities for systemic therapy
This article dials with the new opportunities for the treatment of HER2-positive breast cancer with the involvement of the central nervous system (CNS). In CEREBEL study was shown that trastuzumab was not inferior to lapatinib concerning the reduction the incidence of brain metastases and had statis...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Habib O.N.
2015-06-01
|
Series: | Современная онкология |
Subjects: | |
Online Access: | https://modernonco.orscience.ru/1815-1434/article/view/27003 |